Searchable abstracts of presentations at key conferences in endocrinology

ea0032p738 | Obesity | ECE2013

The FXR agonist obeticholic acid normalizes lipid droplet and triglyceride handling in visceral adipose tissue preadipocytes from a non-genomic rabbit model of metabolic syndrome

Maneschi Elena , Vignozzi Linda , Morelli Annamaria , Mello Tommaso , Filippi Sandra , Cellai Ilaria , Comeglio Paolo , Sarchielli Erica , Calcagno Alessandra , Vettor Roberto , Vannelli Gabriella Barbara , Adorini Luciano , Maggi Mario

Liver and visceral ectopic fatty tissue disposition is a major metabolic derangement leading to type 2 diabetes, hypertension, dyslipidaemia, recapitulated in the metabolic syndrome (MetS). We have demonstrated that the selective FXR agonist obeticholic acid (OCA, INT-747) ameliorates the metabolic profile and reduces visceral adipose tissue (VAT) in a high-fat diet (HFD)-induced rabbit model of MetS. We now report the effects of OCA treatment in HFD (0.5% cholesterol and 4% p...

ea0029p136 | Bone & Osteoporosis | ICEECE2012

Evidence for vitamin D deficiency and increased fractures’ prevalence in autoimmune bullous skin diseases

Eller-Vainicher C. , Marzano A. , Trevisan V. , Cairoli E. , Zhukouskaya V. , Marchese L. , Morelli V. , Beck-Peccoz P. , Crosti C. , Chiodini I.

Background: Vitamin D deficiency plays a role in autoimmune diseases and risk of fractures. No data are available on vitamin D levels and vertebral fractures in autoimmune bullous skin diseases.Objectives: To assess vitamin D serum levels and vertebral fractures’ prevalence in patients with pemphigus vulgaris (PV) and bullous pemphigoid (BP), potentially deadly autoimmune bullous disorders.Methods: We studied 13 consecutive ac...

ea0026p350 | Steroid metabolism | ECE2011

Testosterone supplementation improves adipose tissue function in an animal model of metabolic syndrome

Morelli A , Maneschi E , Vignozzi L , Filippi S , Marchetta M , Mazzanti B , Calcagno A , Comeglio P , Cellai I , Vannelli G B , Maggi M

Introduction: Adipose tissue dysfunction is associated to metabolic syndrome (MetS), a clustering of cardio-metaboilic risk factors, including hypogonadism. We recently demonstrated that T supplementation was able to ameliorate the metabolic profile and reduce visceral fat accumulation in high-fat diet (HFD)-induced rabbit model of MetS.Methods: We evaluated the differentiation capacity of preadipocytes (rPAD) obtained from visceral fat of the following ...

ea0016p672 | Steroid receptors | ECE2008

The vitamin D receptor agonist elocalcitol up-regulates L-type Ca2+ channel activity in human and rat bladder

Morelli Annamaria , Squecco Roberta , Francini Fabio , Failli Paola , Filippi Sandra , Chavalmane Aravinda , Fibbi Benedetta , Mancina Rosa , Vignozzi Linda , Silvestrini Enrico , Gacci Mauro , Colli Enrico , Adorini Luciano , Maggi Mario

Human bladder contraction mainly depends on Ca2+ influx, via L-type voltage-gated Ca2+ channels, and on RhoA/Rho-kinase contractile signalling, a pathway up-regulated in overactive bladder (OAB) syndrome. Elocalcitol (Elo) is a vitamin D receptor agonist inhibiting RhoA/Rho-kinase signalling in rat and human bladder, shown to ameliorate OAB symptoms in a clinical study. Since in normal bladder from Sprague–Dawley (SD) rats Elo treatment delayed the c...

ea0014oc11.3 | Reproductive endocrinology II | ECE2007

Sex steroid and leptin regulation of KISS1/GPR54 system, a new regulator of the neuroendocrine reproductive axis, in human fetal GnRH-secreting neurons

Morelli Annamaria , Marini Mirca , Mancina Rosa , Vignozzi Linda , Pezzatini Anna , Luconi Michaela , Mungai Sara , Fibbi Benedetta , Filippi Sandra , Barbara Vannelli Gabriella , Forti Gianni , Maggi Mario

The molecular mechanisms underlying the reawakening of hypothalamic GnRH neurons at puberty remain to be elucidated. Recently, the G protein-coupled receptor 54 (GPR54) and its endogenous ligand kisspeptin, encoded by the KISS1 gene, have been involved. In fact, GPR54 mutations cause idiopathic hypogonadotropic hypogonadism in human and mice. We used the previously characterized primary culture of human fetal olfactory GnRH-secreting neurons, FNC-B4, to study in vitro t...

ea0014p624 | (1) | ECE2007

Testosterone regulates RhoA/Rho-kinase signalling in two distinct animal models of chemical diabetes

Vignozzi Linda , Morelli Annamaria , Filippi Sandra , Ambrosini Stefano , Mancina Rosa , Luconi Michaela , Mungai Sara , Barbara Vannelli Gabriella , Zhang Xin-Hua , Forti Gianni , Maggi Mario

The contractile RhoA/Rho-kinase (Rock) signalling pathway is up-regulated in penile tissue in animal models of experimental diabetes and has been proposed to contribute to diabetes-related erectile dysfunction (ED). In previous studies we demonstrated that testosterone (T) restores diabetes-induced ED by influencing the NO/cGMP/PDE5 pathway.AimTo investigate the effect of T on the RhoA/Rock signalling in course of diabetes.MethodsWe used two distinct animal models of chemical ...

ea0014p627 | (1) | ECE2007

Characterization and functional role of an androgen-dependent PDE5 activity in bladder

Filippi Sandra , Morelli Annamaria , Sandner Peter , Fibbi Benedetta , Mancina Rosa , Marini Mirca , Gacci Mauro , Vignozzi Linda , Barbara Vannelli Gabriella , Carini Marco , Forti Gianni , Maggi Mario

Benign prostate hyperplasia (BPH) is the most common disease in the aging male, often comorbid with erectile dysfunction (ED). PDE5 inhibitors (PDE5i, sildenafil, tadalafil and vardenafil) decrease lower urinary tract symptoms (LUTS) in patients with ED and BPH. We studied PDE5 expression and activity in the human bladder and PDE5i effects both in vitro (human and rat) and in vivo (rat). PDE5 is highly expressed in rat and human bladder and immunolocalized in vas...

ea0011p682 | Reproduction | ECE2006

Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat

Vignozzi L , Morelli A , Filippi S , Donati S , Luconi M , Zhang XH , Ambrosini S , Vannelli GB , Mirone V , Forti G , Maggi M

Objectives: Radical prostatectomy is an effective therapy for clinically localized prostate cancer. A significant number of men develops post-prostatectomy erectile dysfunction (PPED), due to surgery-related nervous damage. PPED is relatively refractory to PDE5i therapy. In a rat model of bilateral cavernous neurotomy we evaluated whether chronic tadalafil treatment (CTT) could ameliorate anatomical and functional damage to corpora cavernosa (CC).Methods...

ea0056p14 | Adrenal cortex (to include Cushing's) | ECE2018

Preoperative treatment with metyrapone in patient with Cushing’s syndrome due to adrenal adenoma: a pilot prospective study

Puglisi Soraya , Perotti Paola , Barbot Mattia , Cosio Paolo , Scaroni Carla , Stigliano Antonio , Lardo Pina , Morelli Valentina , Polledri Elisa , Chiodini Iacopo , Reimondo Giuseppe , Pia Anna , Terzolo Massimo

Background and objectives: Metyrapone has been approved for the treatment of patients with Cushing’s syndrome from all causes, but only few retrospective clinical studies are available. The aim of our study was the prospective assessment of metyrapone as pre-operative treatment.Methods: Before adrenalectomy, 7 patients with ACTH-independent Cushing’s syndrome due to adrenal adenoma were prospectively treated with metyrapone for 3 months, with e...

ea0056p59 | Adrenal cortex (to include Cushing's) | ECE2018

Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas

Sbardella Emilia , Minnetti Marianna , D'Aluisio Denise , Rizza Laura , Di Giorgio Maria Rosaria , Pofi Riccardo , Giannetta Elisa , Vestri Annarita , Venneri Mary Anna , Morelli Sergio , Lenzi Andrea , Isidori Andrea M

Introduction: Low-grade incomplete post-dexamethasone cortisol suppression in patients with adrenal incidentalomas, recently redefined as possible autonomous cortisol secretion (pACS), has been associated with increased cardiovascular events and mortality. However, prospective studies documenting cardiac abnormalities in these patients are lacking.Methods: In the context of ERGO trial NIH (NCT02611258), between July 2016 and September 2017, 71 consecutiv...